| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/09/2006 | US20060052597 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 03/09/2006 | US20060052594 New corticosteroids |
| 03/09/2006 | US20060052455 Composition for preventing treating the xepression of clinical symptom in disease caused by mitochondrial dysfunction |
| 03/09/2006 | US20060052453 Agent for treating Parkinson's disease comprising astrocyte function-improving agent as active ingredient |
| 03/09/2006 | US20060052439 Salvinorin derivatives and uses thereof |
| 03/09/2006 | US20060052429 Oromucosal formulation and process for preparing the same |
| 03/09/2006 | US20060052428 Neurological functions |
| 03/09/2006 | US20060052426 Acylaminothiazole derivatives, their preparation and their therapeutic use |
| 03/09/2006 | US20060052411 Immunosuppressants, analgesics, antiinflammatory agents |
| 03/09/2006 | US20060052409 Therapeutic or preventive agent for nausea/vomiting |
| 03/09/2006 | US20060052407 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 03/09/2006 | US20060052406 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 03/09/2006 | US20060052397 Compounds for trearment of cardiovascular disorders and hypotensive agents |
| 03/09/2006 | US20060052396 Arylamines for the treatment of conditions associated with gsk-3 |
| 03/09/2006 | US20060052393 Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
| 03/09/2006 | US20060052392 Isoindoline derivative |
| 03/09/2006 | US20060052389 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 03/09/2006 | US20060052388 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 03/09/2006 | US20060052385 For therapy of neurological disorder |
| 03/09/2006 | US20060052377 2-(Alpha-phenylthiobenzyl)morpholine derivatives, e.g., (4-fluorophenyl){[2-methoxyphenyl]thio}methyl)morpholine; serotonin and norepinephrine reuptake inhibitors |
| 03/09/2006 | US20060052371 2-(3-cyanophenyl)-4H-1,3-benzothiazin-4-one; cardiovascular, bone or joint diseases, infectious, inflammatory, kidney diseases; safe and good effects of cell death inhibition, Migration Inhibitory Factor (MIF) binding |
| 03/09/2006 | US20060052368 Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists |
| 03/09/2006 | US20060052364 Pharmaceutical composition for treating pain comprising oxicarbazepine, or derivatives thereof, and cox2 inhibitors |
| 03/09/2006 | US20060052329 Regulation of human P2Y1-like G protein-coupled receptor |
| 03/09/2006 | US20060052315 Cb 1/cb 2 receptor ligands and their use in the treatment of pain |
| 03/09/2006 | US20060052309 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 03/09/2006 | US20060052280 Diagnostic and therapeutic use of a golgi protein for neurodegenerative diseases |
| 03/09/2006 | US20060051867 Cell growth |
| 03/09/2006 | US20060051836 Molecules for disease detection and treatment |
| 03/09/2006 | US20060051835 Pael receptor, cells and animal expressing pael receptor and method of screning remedy for parkinson's disease |
| 03/09/2006 | US20060051438 Herbal medicaments for the treatment of neurocerebrovascular disorders |
| 03/09/2006 | US20060051433 Composition for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs |
| 03/09/2006 | US20060051423 Chitosan-based transport system |
| 03/09/2006 | US20060051376 Remedy for fibromyalgia |
| 03/09/2006 | US20060051375 Rabbit skin comprising biological active substances and its use |
| 03/09/2006 | US20060051357 Tolerance induction with help of a combination of a lfa-1 inhibitor and a costimulation inhibitor and or a mtor inhibitor |
| 03/09/2006 | US20060051356 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 03/09/2006 | US20060051349 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/09/2006 | US20060051344 Antibody and utilization of the same |
| 03/09/2006 | US20060051331 Optimization of transgene expression in mammalian cells |
| 03/09/2006 | US20060051322 Method for therapy of neurodegenerative disease of the brain |
| 03/09/2006 | US20060051293 noninvasive technique for imaging and quantitating amyloid deposits; 2-phenyl- imidazo [1,2,a] pyridine derivatives; radiolabelling; drug delivery; 2-(4'-dimethylaminophenyl)-6-iodobenzothiazole |
| 03/09/2006 | DE102004042253A1 Vegetable active agent, useful for treating multiple sclerosis, comprises bark of plants types of Salix ivigtutiana, Salix reticulata, Salix pyrenaica or bark of plant species in the region of alpine- and Nordic meadows |
| 03/09/2006 | DE102004040006A1 Pharmazeutische Zusammensetzung, umfassend Galaktose, Selen, Vitamin E und/oder Phosphatidylcholin und pharmazeutische Verwendung von Galaktose A pharmaceutical composition comprising galactose, selenium, vitamin E and / or phosphatidylcholine and pharmaceutical use of galactose |
| 03/09/2006 | DE10019195B4 Reversible Immortalisierung Reversible immortalization |
| 03/09/2006 | CA2617601A1 Methods and materials relating to enhanced production of dopamine neurons |
| 03/09/2006 | CA2579012A1 Use of il-6 in vascular complications |
| 03/09/2006 | CA2578781A1 Fused tricyclic derivatives for the treatment of psychotic disorders |
| 03/09/2006 | CA2578604A1 Piperidine derivative or pharmaceutically acceptable salt thereof |
| 03/09/2006 | CA2578552A1 Medicinal composition for percutaneous perospirone administration |
| 03/09/2006 | CA2578347A1 Mitochondria activators |
| 03/09/2006 | CA2577392A1 Methods of treatment of amyloidosis using ethanol cyclicamine derivatives aspartyl protease inhibitors |
| 03/09/2006 | CA2577268A1 Neuroprotective effect of solubilized udca in focal ischemic model |
| 03/09/2006 | CA2576924A1 Amide derivatives of 7-amino-3-phenyl-dihydropyrimido [4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents |
| 03/09/2006 | CA2576839A1 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 03/09/2006 | CA2576812A1 Method for the treatment of attention deficit hyperactivity disorder |
| 03/09/2006 | CA2576782A1 Methods of treatment of amyloidosis using substituted ethanolcyclicamine aspartyl protease inhibitors |
| 03/08/2006 | EP1632492A1 Tricyclic compound |
| 03/08/2006 | EP1632488A1 Cyclic tertiary amine compound |
| 03/08/2006 | EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 03/08/2006 | EP1632479A2 Piperazine derivatives useful as ccr5 antagonists |
| 03/08/2006 | EP1632477A1 Benzamide derivative or salt thereof |
| 03/08/2006 | EP1632475A1 Sertraline hydrochloride polymorphs |
| 03/08/2006 | EP1632474A1 Sertraline hydrochloride polymorphs |
| 03/08/2006 | EP1632473A1 Sertraline hydrochloride polymorphs |
| 03/08/2006 | EP1632472A1 Sertraline hydrochloride polymorphs |
| 03/08/2006 | EP1632471A1 Racemic and optically pure metabolites of Sibutramine, their preparation, compositions comprising them and their use as Dopamine reuptake inhibitors |
| 03/08/2006 | EP1632242A2 Novel method for down-regulation of amyloid |
| 03/08/2006 | EP1632241A1 Preventive and/or remedy for diseases accompanied by tissue destruction |
| 03/08/2006 | EP1632235A2 Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders |
| 03/08/2006 | EP1632234A2 (S,S)-reboxetine for treating chronic fatigue syndrome |
| 03/08/2006 | EP1632230A1 Neurocyte protective agent |
| 03/08/2006 | EP1632227A1 Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction |
| 03/08/2006 | EP1632224A1 Spill resistant pharmaceutical compositions |
| 03/08/2006 | EP1631568A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 03/08/2006 | EP1631559A2 Il-8 receptor antagonists |
| 03/08/2006 | EP1631557A1 Cyclic hydroxylamine as psychoactive compounds |
| 03/08/2006 | EP1631546A1 Sustituted indoline and indole derivatives |
| 03/08/2006 | EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 03/08/2006 | EP1631302A1 Migraine remedy |
| 03/08/2006 | EP1631298A1 Glycosaminoglycans for treating emotional dysfunctions |
| 03/08/2006 | EP1631296A1 2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease |
| 03/08/2006 | EP1631294A1 A method of treating an anxiety disorder |
| 03/08/2006 | EP1631288A1 Positive modulators of nicotinic acetylcholine receptors |
| 03/08/2006 | EP1631285A1 Therapeutic agents useful for treating pain |
| 03/08/2006 | EP1631282A1 Use of the hydrochloride of the active ingredient base 1-[n2-[3,5-dibromo-n-[[4-(3,4-dihydro-2(1h)-oxoquinazolin-3-yl)-1-piperidinyl]-carbonyl]-d-tyrosyl]-l-lysyl]-4-(4-pyridinyl)-piperazine combined with sumatriptan for the treatment of migraines |
| 03/08/2006 | EP1631281A2 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit |
| 03/08/2006 | EP1631280A1 Use of triglyceride oils containing gamma-linolenic acid residues and linoleic acid residues for the treatment of a neurodegenerative disease |
| 03/08/2006 | EP1631270A2 Methods and compositions for delivery of catecholic butanes for treatment of diseases |
| 03/08/2006 | EP1494703B1 Chemokines mutants having improved oral bioavailability |
| 03/08/2006 | EP1492781B1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics |
| 03/08/2006 | EP1465627B1 DOSING REGIMEN FOR PPAR−GAMMA ACTIVATORS |
| 03/08/2006 | EP1455602B1 Modified methionine rich food products and process for their manufacture |
| 03/08/2006 | EP1451167B1 Phenylalkynes |
| 03/08/2006 | EP1448592B1 Steroidal compounds for inhibiting steroid sulphatase |
| 03/08/2006 | EP1446393B1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 03/08/2006 | EP1445252B1 Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
| 03/08/2006 | EP1404667B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 03/08/2006 | EP1365761B1 Therapeutic combination of amlodipine and benazepril |
| 03/08/2006 | EP1347966B1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |